YolTech Therapeutics
PrivateLast Round
Series C
May 28, 2026
Total Funding Raised
$147M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
YolTech Therapeutics is a biotechnology company that develops in vivo gene-editing therapies for serious genetic, metabolic, and cardiovascular diseases using proprietary CRISPR-Cas and lipid nanoparticle delivery platforms.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
YolTech Therapeutics Comparables
Compare YolTech Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Arbor Biotechnologies | 83% | |
| CorrectSequence Therapeutics | 82% | |
| Base Therapeutics | 82% |
YolTech Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | May 28, 2026 | ||||
| Series B | Sep 11, 2025 | ||||
| Series A Extension | Nov 1, 2023 | ||||
| Series A | Aug 1, 2022 |
YolTech Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Loyal Valley Capital | Series C |
| Unity Ventures | Series A |
| 险峰K2VC | Series C, Series A |
| 松禾资本 (Green Pine Capital Partners) | Series B |
| Decheng Capital | Series B, Series A Extension |
| Grand Flight Investment | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 11, 2025
$45M round led by AstraZeneca-CICC Healthcare Industrial Fund.
YolTech Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about YolTech Therapeutics's valuation, stock price, and market status.
Is YolTech Therapeutics a public or private company?
YolTech Therapeutics is a private company.
What is the current stock price of YolTech Therapeutics?
YolTech Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is YolTech Therapeutics worth (valuation)?
Valuation information for YolTech Therapeutics is not publicly available.
Can I buy YolTech Therapeutics stock?
YolTech Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was YolTech Therapeutics's last funding round?
YolTech Therapeutics's most recent funding round was Series C on May 28, 2026.
Who are the main investors in YolTech Therapeutics?
Key investors in YolTech Therapeutics include Loyal Valley Capital, Decheng Capital.
Will YolTech Therapeutics IPO soon?
No public IPO plans have been announced for YolTech Therapeutics.
How can I track YolTech Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor YolTech Therapeutics's secondary market activity and sign up for updates.